The funny thing is that if 2RT were listed on its own, the valuation would probably be much larger than Nova Eye's valuation today. The market has a way of getting imaginative pricing in all the "potential" when the company isn't making money, but as soon as it does start making money it applies a simple multiple to revenue/earnings and completely ignores the pipeline (which is why I really love investing in medical companies currently generating decent revenue, but with a very large pipeline not being priced in at all)
The funny thing is that if 2RT were listed on its own, the...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.025(8.62%) |
Mkt cap ! $60.63M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 26.5¢ | $332.8K | 1.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 121450 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 154073 | 4 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |